CRAFT: Cerclage After Full Dilatation Caesarean Section

Sponsor
Guy's and St Thomas' NHS Foundation Trust (Other)
Overall Status
Recruiting
CT.gov ID
NCT04110704
Collaborator
King's College London (Other), University College, London (Other)
1,000
1
2
36
27.8

Study Details

Study Description

Brief Summary

CRAFT-OBS: Observational Study; To evaluate subsequent pregnancy risk of preterm birth in women with a history of previous caesarean in established labour. This prospective study using clinically acquired cervical length and quantitative fetal fibronectin data will help establish a predictive model of preterm birth <34 weeks and <37 weeks.

CRAFT-RCT: Randomised controlled trial arm; To assess treatment for short cervix in women at high risk of preterm birth following a caesarean section at full dilatation

CRAFT-IMG: Imaging sub-study; To aid understanding of micro and macrostructural features within the cervix which predisposes to preterm birth in women with a previous full dilatation caesarean section. This will use MRI and an advanced transvaginal ultrasound protocol and to assess if structural changes can be visualised in the cervix.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Insertion of transvaginal cerclage
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1000 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
An Investigation Into the Role of Previous in Labour Caesarean Section in Future Preterm Birth Risk and Management Strategies
Actual Study Start Date :
Oct 2, 2019
Anticipated Primary Completion Date :
Apr 1, 2022
Anticipated Study Completion Date :
Oct 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Transvaginal cerclage

Procedure: Insertion of transvaginal cerclage
Transvaginal cerclage is inserted in women with a high risk of preterm birth. However it is unknown whether this alongside cervical length monitoring improves the incidence of preterm birth. The cerclage is inserted under regional analgesia.

No Intervention: Active monitoring

Outcome Measures

Primary Outcome Measures

  1. CRAFT-OBS: Number of participants with spontaneous preterm birth rate < 37 weeks gestation [Up to 42 weeks]

  2. CRAFT-RCT: Number of participants with spontaneous preterm birth <34 weeks gestation [Up to 42 weeks]

Secondary Outcome Measures

  1. CRAFT-OBS: Short-term pregnancy and neonatal outcomes, including a composite of neonatal death and morbidity. [Up to 48 weeks]

    We will assess the number of antepartum/intrapartum stillbirths plus neonatal deaths prior to discharge from neonatal services.

  2. CRAFT-OBS: Number of participants with adverse perinatal outcome, defined as a composite outcome of death (antepartum/intrapartum stillbirths plus neonatal deaths prior to discharge from neonatal services) [Up to 48 weeks]

  3. CRAFT-OBS: Number of participants who deliver <34 weeks gestation [Up to 42 weeks]

  4. CRAFT-OBS: Gestation at delivery [Up to 42 weeks]

    The proportion of participants who delivery at each gestation of completed weeks

  5. CRAFT-OBS: Late miscarriage (14+0-23+6 weeks) rate [Up to 42 weeks]

  6. CRAFT-OBS: Any cervical length measurements taken antenatally [Up to 42 weeks]

  7. CRAFT-OBS: Number of antenatal hospital appointments [Up to 42 weeks]

  8. CRAFT-OBS: Number of hospital admissions [Up to 42 weeks]

  9. CRAFT-OBS: cervicovaginal fetal fibronectin protein levels taken at any gestation if taken [Up to 42 weeks]

  10. CRAFT-OBS: Number of ultrasound indicated antenatal interventions [Up to 42 weeks]

  11. CRAFT-OBS: Predictive modelling (QUIPP app) to evaluate the ability of CL and fFN to determine risk of preterm birth <34 and <37 weeks [Up to 42 weeks]

  12. CRAFT-OBS: Number of participants with other maternal and fetal morbidities, as per COPOP core outcome set for preterm birth intervention studies [Up to 48 weeks]

    COPOP core outcomes

  13. CRAFT-RCT: Number of participants with an adverse perinatal outcome [Up to 48 weeks]

  14. CRAFT-RCT: Gestation at delivery [Up to 42 weeks]

    Proportion of participants who deliver at each gestation of completed weeks

  15. CRAFT-RCT: Number of women needing insertion of a rescue cerclage (done when membranes exposed or bulging) [Up to 30 weeks]

  16. CRAFT-RCT: Time between intervention and delivery. [Up to 42 weeks]

  17. CRAFT-RCT - Health costs at 28 days post-delivery. [Up to 48 weeks]

  18. CRAFT-IMG: Evidence of cervical injury [Up to 40 weeks]

    Size of any cervical lesion and its location seen on MRI or ultrasound scans

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes

CRAFT-OBS

Inclusion Criteria:
  • Pregnant women under 23+6 weeks gestation with a history of previous caesarean section in labour.

  • Singleton pregnancy.

  • Willing and able to give informed consent (with or without interpreter).

Exclusion Criteria:
  • Under 16 years of age.

  • Inability to give informed consent.

  • Previous caesarean section carried out before labour.

  • Women who have been commenced on management with progesterone, a cerclage or arabin pessary as part of their care or another research study

CRAFT-RCT:
Inclusion criteria:
  • Pregnant women up to 23+6 weeks gestation with a history of FDCS.

  • Short cervix (<=25mm) on transvaginal ultrasound scan.

Exclusion criteria:
  • Women with persistent fresh vaginal bleeding evident on speculum examination.

  • Women with visible fetal membranes evident on speculum examination or open cervix on ultrasound scan.

  • Women with severe abdominal pain/evidence of sepsis (as judged by attending clinician).

  • Known significant congenital or structural or chromosomal fetal abnormality.

  • Suspected or proven rupture of the fetal membranes at the time of recruitment.

CRAFT-IMG

Inclusion criteria:
  • Pregnant women between 14+0 and 23+6 weeks gestation with a history of FDCS.
Exclusion criteria:
  • Contraindications to MRI, e.g. claustrophobia, BMI >40 kg/m2 (due to technical limitations of scanner) or a women with a non-MRI compatible metallic implant.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Guy's and St Thomas' Hospital NHS Foundation Trust London United Kingdom SE1 7EH

Sponsors and Collaborators

  • Guy's and St Thomas' NHS Foundation Trust
  • King's College London
  • University College, London

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Guy's and St Thomas' NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT04110704
Other Study ID Numbers:
  • 261294
  • 42833
First Posted:
Oct 1, 2019
Last Update Posted:
Jul 28, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 28, 2021